Nu-Med Plus (NUMD) Receivables (2023)
Nu-Med Plus (NUMD) posted Receivables of $3500.0 for Q1 2023.
Nu-Med Plus (NUMD) Receivables (2023) Analysis & Trends
Nu-Med Plus has reported Receivables for 1 years, with the latest figure at $3500.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3,500.00 |